93 related articles for article (PubMed ID: 12172957)
1. Correlation of a novel matrix protein with the degree of cartilage degradation.
Schmidt-Rohlfing B; Schneider U; Thomsen M; Bosserhoff AK
Rheumatol Int; 2002 Aug; 22(4):165-9. PubMed ID: 12172957
[TBL] [Abstract][Full Text] [Related]
2. Cartilage-derived retinoic acid-sensitive protein in equine synovial fluid from healthy and diseased joints.
Berg LC; Lenz J; Kjelgaard-Hansen M; Thomsen PD; Jacobsen S
Equine Vet J; 2008 Sep; 40(6):553-7. PubMed ID: 18267886
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization and chromosomal assignment of equine cartilage derived retinoic acid sensitive protein (CD-RAP)/melanoma inhibitory activity (MIA).
Berg LC; Mata X; Thomsen PD
Gene; 2008 Jan; 407(1-2):98-104. PubMed ID: 17977671
[TBL] [Abstract][Full Text] [Related]
4. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
5. Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma.
Bosserhoff AK; Kondo S; Moser M; Dietz UH; Copeland NG; Gilbert DJ; Jenkins NA; Buettner R; Sandell LJ
Dev Dyn; 1997 Apr; 208(4):516-25. PubMed ID: 9097023
[TBL] [Abstract][Full Text] [Related]
6. [Osteochondral marker proteins in the quantitative evaluation of matrix-based autologous chondrocyte transplantation CaRes].
Gravius S; Schneider U; Mumme T; Bauer D; Maus U; Müller-Rath R; Berdel P; Siebert C; Andereya S
Z Orthop Unfall; 2007; 145(5):625-32. PubMed ID: 17939074
[TBL] [Abstract][Full Text] [Related]
7. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma.
Bosserhoff AK; Kaufmann M; Kaluza B; Bartke I; Zirngibl H; Hein R; Stolz W; Buettner R
Cancer Res; 1997 Aug; 57(15):3149-53. PubMed ID: 9242442
[TBL] [Abstract][Full Text] [Related]
8. Effects of moving training on histology and biomarkers levels of articular cartilage.
Qi C; Changlin H
J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690
[TBL] [Abstract][Full Text] [Related]
9. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
10. Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint.
Maiotti M; Monteleone G; Tarantino U; Fasciglione GF; Marini S; Coletta M
Arthroscopy; 2000; 16(5):522-6. PubMed ID: 10882449
[TBL] [Abstract][Full Text] [Related]
11. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
[TBL] [Abstract][Full Text] [Related]
12. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
14. Correlation of bone and cartilage markers in the synovial fluid with the degree of osteoarthritis.
Schmidt-Rohlfing B; Thomsen M; Niedhart C; Wirtz DC; Schneider U
Rheumatol Int; 2002 Mar; 21(5):193-9. PubMed ID: 11958436
[TBL] [Abstract][Full Text] [Related]
15. Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis.
Vandooren B; Cantaert T; van Lierop MJ; Bos E; De Rycke L; Veys EM; De Keyser F; Bresnihan B; Luyten FP; Verdonk PC; Tak PP; Boots AH; Baeten D
Ann Rheum Dis; 2009 Jun; 68(6):1044-50. PubMed ID: 18633128
[TBL] [Abstract][Full Text] [Related]
16. [Biological markers of osteoarthritis].
Thonar EJ; Manicourt DH
Rev Rhum Ed Fr; 1994 Nov; 61(9 Pt 2):99S-102S. PubMed ID: 7858614
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
18. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
Squires GR; Okouneff S; Ionescu M; Poole AR
Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cartilage-derived retinoic-acid-sensitive protein (CD-RAP) in synovial fluid from patients with osteoarthritis and rheumatoid arthritis.
Saito S; Kondo S; Mishima S; Ishiguro N; Hasegawa Y; Sandell LJ; Iwata H
J Bone Joint Surg Br; 2002 Sep; 84(7):1066-9. PubMed ID: 12358374
[TBL] [Abstract][Full Text] [Related]
20. New potential markers for cartilage degradation of the knee joint.
Schmidt-Rohlfing B; Gavenis K; Kippels M; Schneider U
Scand J Rheumatol; 2002; 31(3):151-7. PubMed ID: 12195629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
